{
 "PrintNo":"S5304","Session":2023,"Chamber":"SENATE","BillType":"Senate","Published":"2023-03-01T16:03:20.699569Z",
 "Status":"IN_SENATE_COMM","Committee":"Higher Education",
 "Milestones":[{"Type":"IN_SENATE_COMM","Date":"2024-01-03","Committee":"Higher Education"}],
 "Actions":[
  {"Text":"REFERRED TO HIGHER EDUCATION","Date":"2023-03-01","Chamber":"SENATE"},
  {"Text":"REFERRED TO HIGHER EDUCATION","Date":"2024-01-03","Chamber":"SENATE"}
 ],
 "Sponsors":[{"ID":1520,"Name":"Nathalia Fernandez","Short":"FERNANDEZ"}],
 "Title":"Relates to the definition of the practice of pharmacy; repealer",
 "Summary":"Relates to the definition of the practice of pharmacy; provides that the state board of pharmacy shall not adopt any rules authorizing a pharmacist to prescribe a controlled drug; repeals provisions related to the collaborative drug therapy management demonstration program.",
 "LawSection":"Education Law","LawCode":"Amd ยง6801, rpld ยง6801-a, Ed L",
 "ActClause":"AN ACT to amend the education law, in relation to the definition of the practice of pharmacy; and to repeal section 6801-a of the education law, relating to the collaborative drug therapy management demonstration program"
}